Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as it marks Bio-Thera’s third EC approvedproduct” said Shengfeng Li, CEO at Bio-Thera. “Bio-Thera is committed toexpanding access fo...
View DetailsGuangzhou, China / Jeddah, Saudi Arabia – September 15,2025 –Bio-Thera Solutions Inc.(688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars Under the agreement, Jamjoom Pharma will obta...
Guangzhou,China– September 10, 2025 –Bio-TheraSolutions Inc. (688177:SH),a commercial-stage biopharmaceutical company developing a pipeline ofinnovative therapies and biosimilars, today announced that the MHRA hasapproved Qletli® (adalimumab), a bios...
Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as it marks Bio-Thera’s third EC approvedproduct” said Shengfeng Li, CEO at Bio-Thera. “Bio-Thera is committed toexpanding access fo...
